Sun Pharma Canada Inc a wholly owned subsidiary of Sun Pharmaceuticals Industries announced the launch of CEQUA a new treatment for Canadians living with dry eye disease CEQUA cyclosporine ophthalmic solution 009Percentage wv a calcineurin inhibitor immunomodulator is the first dry eye treatment available in Canada that is delivered with nanomicellar NCELL technology which improves the bioavailability and physicochemical stability of cyclosporine to increase ocular tissue penetration
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
